Authors:
Laffin, RJ
Chan, DW
Tanasijevic, MJ
Fischer, GA
Markus, W
Miller, J
Matarrese, P
Sokoll, LJ
Bruzek, DJ
Eneman, J
Nelson, J
Bray, KR
Huang, J
Loveland, KG
Citation: Rj. Laffin et al., Hybritech total and free prostate-specific antigen assays developed for the Beckman Coulter access automated chemiluminescent immunoassay system: A multicenter evaluation of analytical performance, CLIN CHEM, 47(1), 2001, pp. 129-132
Authors:
Delgado, JC
Shulman, LN
Gudrais, PG
Fischer, GA
Ferguson, DO
Winkelman, JW
Tanasijevic, MJ
Citation: Jc. Delgado et al., Standardization of carcinoembryonic antigen testing in the setting of clinical laboratory consolidation, LAB MED, 32(2), 2001, pp. 92-95
Authors:
Srinivas, VS
Cannon, CP
Gibson, CM
Antman, EM
Greenberg, MA
Tanasijevic, MJ
Murphy, S
de Lemos, JA
Sokol, S
Braunwald, E
Mueller, HS
Citation: Vs. Srinivas et al., Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: A thrombolysis in myocardial infarction 10B substudy, AM HEART J, 142(1), 2001, pp. 29-36
Citation: Jc. Delgado et al., Comparison of disaturated phosphatidylcholine and fetal lung maturity surfactant/albumin ratio in diabetic and nondiabetic pregnancies, AM J CLIN P, 113(2), 2000, pp. 233-239
Authors:
Morrow, DA
Rifai, N
Tanasijevic, MJ
Wybenga, DR
De Lemos, JA
Antman, EM
Citation: Da. Morrow et al., Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: A thrombolysis in myocardial infarction(TIMI) 11B substudy, CLIN CHEM, 46(4), 2000, pp. 453-460
Authors:
McElrath, TF
Norwitz, ER
Robinson, JN
Tanasijevic, MJ
Lieberman, ES
Citation: Tf. Mcelrath et al., Differences in TDx fetal lung maturity assay values between twin and singleton gestations, AM J OBST G, 182(5), 2000, pp. 1110-1112
Authors:
Kuperman, GJ
Teich, JM
Tanasijevic, MJ
Ma'Luf, N
Rittenberg, E
Jha, A
Fiskio, J
Winkelman, J
Bates, DW
Citation: Gj. Kuperman et al., Improving response to critical laboratory results with automation: Resultsof a randomized controlled trial, J AM MED IN, 6(6), 1999, pp. 512-522
Authors:
Tanasijevic, MJ
Cannon, CP
Antman, EM
Wybenga, DR
Fischer, GA
Grudzien, C
Gibson, CM
Winkelman, JW
Braunwald, E
Citation: Mj. Tanasijevic et al., Myoglobin, creatine-kinase-MB and cardiac Troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction - Results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B, J AM COL C, 34(3), 1999, pp. 739-747
Citation: Mj. Tanasijevic et al., The role of cardiac troponin-I (cTnI) in risk stratification of patients with unstable coronary artery disease, CLIN CARD, 22(1), 1999, pp. 13-16
Authors:
Chan, DW
Kelley, CA
Ratliff, TL
D'Agostino, D
Ritchey, J
Lamb, DJ
Beck, J
Lott, N
Wener, MH
Daum, P
Henkin, RE
Kaske, DN
Golightly, DW
McBride, J
Layco, G
Ota, MK
Tanasijevic, MJ
Grudzien, C
Woodrum, DL
Bray, KR
Southwick, PC
Gasior, GH
Loveland, KG
Citation: Dw. Chan et al., Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine theclinical utility of percentage of free prostate-specific antigen, CLIN CHEM, 45(10), 1999, pp. 1863-1865
Citation: Mj. Tanasijevic et Em. Antman, Diagnostic performance of cardiac troponin I in suspected acute myocardialinfarction: Implications for clinicians, AM HEART J, 137(2), 1999, pp. 203-206